New Content  edit
Get The App!

Loading the player...
Clinical Discussion Regarding Choice of Therapy for Polycythemia Vera (PV)
Share URL
Embed Code
Share by Email
Send to social websites
Report this video as inappropriate You can report this video if you think it to be inappropriate, we will review your submission soon. If your reason is not listed here, like copyright infringements, please contact us directly by email. Select your reason
Sexual Content Violent or Repulsive Content
Hateful or Abusive Content Harmful Dangerous Acts
Child Abuse Spam
Richard Silver MD, Rubin Mesa MD, Serge Verstovsek MD, and Susan J. Leclair, PhD, CLS (NCA) relate their clinical experiences with addressing diverse aspects of PV. PV is a multifaceted disease characterized by overproduction of red blood cells, increased thrombosis risk, splenomegaly, high symptom burden, and the potential for progression to post-PV myelofibrosis (post-PV MF).